Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc
 
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 28,
Hindmarsh,
South Australia 5007

Office:
Suite 506,
North Terrace House,
19 North Terrace,
Hackney, SA, 5069


Phone:
1300 128 339

Office Hours:
Wednesdays, 11am-3pm

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 242KB)
Why become a member?
 

Experts probe challenges of Chronic Fatigue Syndrome

Thursday 21 July 2011

From the US's National Institutes of Health:

 

Dr. Harvey Alter
The Clinical Center’s Dr. Harvey Alter
participates in the recent workshop
on chronic fatigue syndrome.

NIH Record

Experts Probe Challenges of Chronic Fatigue Syndrome

NIH recently convened a workshop on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) research on campus. About 75 percent of individuals with this disease recall a dramatic and abrupt change in their health status following a viral-type illness. After feeling fine one day, they wake up the next unable to move, sensitive to loud noises, dizzy when standing and suffer severe headaches. They can’t sleep, have muscle aches, report foggy brains and suffer a debilitating, ongoing and relentless fatigue akin to that experienced with cancer or flu.

However, as is the case with many complex, chronic diseases, a lack of consensus on a case definition and heterogeneity in the patient population is deterring accurate identification of ME/CFS. Diagnosis can take years while symptoms typically devastate the lives of patients and their loved ones. No cure exists for ME/CFS, which is found in about two to four times as many women than men and affects roughly 1 million to 4 million people of all ages, races and ethnic groups in the U.S.

To the frustration of patients and public health officials, the causes of ME/CFS have eluded investigators for more than 35 years. Several virologists highlighted the controversy on the potential association of a retrovirus, XMRV, with ME/CFS, and presented data on the possible role of enteroviruses or herpes viruses in the etiology of the disease. Without known causes, research on ME/CFS has mainly focused on the pathophysiology of the ailment related to immune and neuroendocrine dysfunctions.

Participants at the workshop learned how new systems biology approaches are revealing striking similarities and differences among ME/CFS patients. Still, treatment for these patients is limited to symptom management until a better understanding of the causes is determined.

 

The above originally appeared here.

 


 

blog comments powered by Disqus

Previous Previous Page